ArticleBlood cancer journal2023

E-selectin-targeting lipid nanoparticles improve therapeutic efficacy and reduce side effects of bortezomib in multiple myeloma.

Mina Maksimos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.